Phibro Animal Health Corporation (PAHC) Financial Statements (2025 and earlier)
Company Profile
Business Address |
GLENPOINTE CENTRE EAST, 3RD FLOOR TEANECK, NJ 07666 |
State of Incorp. | DE |
Fiscal Year End | June 30 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 6/30/2024 | 12/31/2023 MRQ | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments, including: | 114,613 | 92,493 | 81,281 | 91,248 | 91,601 | 91,343 | |||
Cash and cash equivalents | 70,613 | 32,970 | 41,281 | 74,248 | 50,212 | 36,343 | |||
Short-term investments | 44,000 | 59,523 | 40,000 | 17,000 | 43,000 | 55,000 | |||
Other undisclosed cash, cash equivalents, and short-term investments | (1,611) | ||||||||
Receivables | 169,452 | 150,627 | 163,479 | 166,537 | 146,852 | 126,522 | |||
Inventory, net of allowances, customer advances and progress billings | 265,911 | 286,680 | 277,570 | 259,158 | 216,312 | 196,659 | |||
Inventory | 265,911 | 286,680 | 277,570 | 259,158 | 216,312 | 196,659 | |||
Other current assets | 51,021 | 56,786 | 63,393 | 49,289 | 42,533 | 37,313 | |||
Other undisclosed current assets | 1,611 | ||||||||
Total current assets: | 600,997 | 586,586 | 585,723 | 566,232 | 498,909 | 451,837 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 37,604 | ||||||||
Property, plant and equipment | 203,300 | 200,839 | 195,568 | 165,490 | 154,706 | 148,109 | |||
Long-term investments and receivables | 5,183 | ||||||||
Long-term investments | 5,183 | ||||||||
Intangible assets, net (including goodwill) | 99,590 | 105,645 | 108,261 | 117,087 | 114,961 | 123,676 | |||
Goodwill | 54,557 | 54,683 | 53,274 | 53,226 | 52,679 | 52,679 | |||
Intangible assets, net (excluding goodwill) | 45,033 | 50,962 | 54,987 | 63,861 | 62,282 | 70,997 | |||
Deferred income tax assets | 19,371 | ||||||||
Other noncurrent assets | 78,297 | 79,638 | 81,845 | 82,890 | 72,749 | 60,478 | |||
Other undisclosed noncurrent assets | (62,158) | ||||||||
Total noncurrent assets: | 381,187 | 386,122 | 385,674 | 365,467 | 342,416 | 332,263 | |||
TOTAL ASSETS: | 982,184 | 972,708 | 971,397 | 931,699 | 841,325 | 784,100 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 144,168 | 132,636 | 124,024 | 192,366 | 154,741 | 138,488 | |||
Taxes payable | ✕ | ✕ | ✕ | ✕ | 7,211 | ||||
Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 34,278 | ||||
Accounts payable | 85,567 | 86,410 | 73,853 | 95,596 | 68,362 | 66,091 | |||
Accrued liabilities | 58,601 | 46,226 | 50,171 | 55,281 | 86,379 | 72,397 | |||
Deferred revenue | 370 | ||||||||
Debt | 29,795 | 26,045 | 22,295 | 15,000 | 9,375 | 18,750 | |||
Other liabilities | 17,540 | 20,892 | 18,859 | 18,904 | |||||
Other undisclosed current liabilities | 12,645 | 8,162 | 10,452 | (35,438) | |||||
Total current liabilities: | 204,148 | 187,735 | 176,000 | 190,832 | 164,116 | 157,238 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation, including: | 282,289 | 297,853 | 311,541 | 417,925 | 297,085 | 368,257 | |||
Long-term debt, excluding current maturities | 282,289 | 297,853 | 311,541 | 417,925 | 382,710 | 368,257 | |||
Other undisclosed long-term debt and lease obligation | (85,625) | ||||||||
Liabilities, other than long-term debt | 120,762 | 65,317 | 72,491 | 60,500 | 61,672 | 70,401 | |||
Accounts payable and accrued liabilities | 6,846 | ||||||||
Deferred income tax liabilities | 667 | 1,714 | |||||||
Liability for uncertainty in income taxes | 13,550 | 10,430 | 5,702 | ||||||
Liability, pension and other postretirement and postemployment benefits | 6,678 | ||||||||
Other liabilities | 63,106 | 65,317 | 60,347 | 60,500 | 55,970 | 70,401 | |||
Operating lease, liability | 29,915 | ||||||||
Derivative instruments and hedges, liabilities | |||||||||
Other undisclosed noncurrent liabilities | 118,344 | 151,000 | 128,856 | 79,923 | |||||
Total noncurrent liabilities: | 521,395 | 514,170 | 512,888 | 478,425 | 438,680 | 438,658 | |||
Total liabilities: | 725,543 | 701,905 | 688,888 | 669,257 | 602,796 | 595,896 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 256,641 | 270,803 | 282,509 | 262,442 | 238,529 | 188,204 | |||
Additional paid in capital | 136,278 | 135,964 | 135,803 | 135,803 | 135,803 | 135,525 | |||
Accumulated other comprehensive loss | (123,527) | (109,615) | (114,210) | (121,113) | (115,293) | (130,385) | |||
Retained earnings | 243,886 | 244,450 | 260,912 | 247,748 | 218,015 | 183,060 | |||
Other undisclosed equity, attributable to parent | 4 | 4 | 4 | 4 | 4 | 4 | |||
Total equity: | 256,641 | 270,803 | 282,509 | 262,442 | 238,529 | 188,204 | |||
TOTAL LIABILITIES AND EQUITY: | 982,184 | 972,708 | 971,397 | 931,699 | 841,325 | 784,100 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 6/30/2024 | 12/31/2023 TTM | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 1,017,679 | 982,014 | 977,889 | 942,261 | 833,350 | 800,354 | ||
Cost of revenue (Cost of Goods and Services Sold) | (704,587) | (683,466) | (679,652) | (656,861) | (561,973) | (543,472) | ||
Gross profit: | 313,092 | 298,548 | 298,237 | 285,400 | 271,377 | 256,882 | ||
Operating expenses | (310,311) | (241,254) | (226,390) | (206,414) | (196,509) | (187,688) | ||
Other undisclosed operating income | 50,534 | |||||||
Operating income: | 53,315 | 57,294 | 71,847 | 78,986 | 74,868 | 69,194 | ||
Nonoperating income (expense) (Gain (Loss), Foreign Currency Transaction, before Tax) | (23,863) | (11,570) | (2,455) | 5,216 | 4,480 | (826) | ||
Interest and debt expense | (462) | (21,721) | (18,676) | (12,691) | (13,718) | (14,613) | ||
Income from continuing operations before equity method investments, income taxes: | 28,990 | 24,003 | 50,716 | 71,511 | 65,630 | 53,755 | ||
Other undisclosed income (loss) from continuing operations before income taxes | (18,074) | 4,128 | 3,355 | 816 | 838 | 1,757 | ||
Income from continuing operations before income taxes: | 10,916 | 28,131 | 54,071 | 72,327 | 66,468 | 55,512 | ||
Income tax expense | (8,500) | (13,332) | (21,465) | (23,152) | (12,083) | (21,960) | ||
Income from continuing operations: | 2,416 | 14,799 | 32,606 | 49,175 | 54,385 | 33,552 | ||
Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 49,175 | 54,385 | 33,552 | |
Net income available to common stockholders, diluted: | 2,416 | 14,799 | 32,606 | 49,175 | 54,385 | 33,552 |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 6/30/2024 | 12/31/2023 TTM | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 2,416 | 14,799 | 32,606 | 49,175 | 54,385 | 33,552 | ||
Other comprehensive income (loss) | 10,984 | 11,419 | 1,230 | 5,195 | (1,478) | |||
Other undisclosed comprehensive income | 1,230 | |||||||
Comprehensive income: | 13,400 | 27,448 | 33,836 | 54,370 | 52,907 | 33,552 | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (20,301) | (5,733) | 5,673 | (11,015) | 16,570 | (44,204) | ||
Comprehensive income (loss), net of tax, attributable to parent: | (6,901) | 21,715 | 39,509 | 43,355 | 69,477 | (10,652) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.